Our recent study confirmed that Fn is a facultatively intracellular bacteria (Xue et al., 2018) that elicits a high level of serum anti-Fn antibodies in CRC patients (Wang et al., 2016). This evidence concerns the gene FN1 and colorectal carcinoma.